(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...
Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...
Inc., a pharmaceutical company specializing in preparations, voted in favor of a reverse stock split and an increase in stock reserves for incentive plans, according to a filing with the Securities ...
In a recent special meeting, shareholders of Eyenovia (NASDAQ:EYEN), Inc., a pharmaceutical company specializing in preparations, voted in favor of a reverse stock split and an increase in stock ...
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its ...
Eyenovia has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.98, meaning that its stock price is 2% less ...
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback